<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: The interval between the T-wave's peak and end (Tpe), an electrocardiographic (ECG) index of ventricular repolarization, has been proposed as an indicator of arrhythmic risk </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to clarify the clinical usefulness of Tpe for risk stratification </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: We evaluated 327 patients with left ventricular ejection fraction (LVEF) ≤ 35% (75% male, LVEF 23 ± 7%) </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had an implanted implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>Clinical data and ECGs were analysed at baseline </plain></SENT>
<SENT sid="5" pm="."><plain>Prospective follow-up for the endpoints of appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy and mortality was conducted via periodic device interrogation, chart review, and the Social Security <z:hpo ids='HP_0011420'>Death</z:hpo> Index </plain></SENT>
<SENT sid="6" pm="."><plain>During device clinic follow-up of 17 ± 12 months, 59 (18%) patients had appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy, and during mortality follow-up of 30 ± 13 months, 67 (21%) patients died </plain></SENT>
<SENT sid="7" pm="."><plain>A longer Tpe(c) predicted appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy, <z:hpo ids='HP_0011420'>death</z:hpo>, and the combination of appropriate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy or <z:hpo ids='HP_0011420'>death</z:hpo> (P&lt; 0.01 for each endpoint) </plain></SENT>
<SENT sid="8" pm="."><plain>On multivariable analysis correcting for other univariable predictors, Tpe(c) remained predictive of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy [hazard ratio (HR) per 10 ms increase: 1.16, P= 0.02], <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality (HR per 10 ms: 1.14, P= 0.03), and the composite endpoint of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy or <z:hpo ids='HP_0011420'>death</z:hpo> (HR per 10 ms: 1.16, P&lt; 0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: In patients with left ventricular systolic dysfunction and an implanted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>, Tpe(c) independently predicts both ventricular tachyarrhythmia and overall mortality </plain></SENT>
</text></document>